Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

The clinical usefulness of salivary progesterone measurement for the evaluation of the corpus luteum function.

Ishikawa M, Sengoku K, Tamate K, Takaoka Y, Kane M, Fottrell PF.

Gynecol Obstet Invest. 2002;53(1):32-7.

PMID:
11803226
2.

Direct colorimetric monoclonal antibody enzyme immunoassay for estradiol-17 beta in saliva.

Tamate K, Charleton M, Gosling JP, Egan D, Ishikawa M, Fottrell PF, Kane MM.

Clin Chem. 1997 Jul;43(7):1159-64.

3.

Validation of a high-performance liquid chromatographic assay for lysylpyridinoline in urine: a potential biomarker of bone resorption.

Casserly UM, O'Rorke A, Power MJ, Fottrell PF.

Anal Biochem. 1996 Nov 15;242(2):255-60.

PMID:
8937570
4.

Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women.

Bolaji II, Mortimer G, Grimes H, Tallon DF, O'Dwyer E, Fottrell PF.

Gynecol Endocrinol. 1996 Feb;10(1):41-7.

PMID:
8737191
5.

Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe.

Mbizvo MT, Mashu A, Chipato T, Makura E, Bopoto R, Fottrell PF.

Cent Afr J Med. 1996 Jan;42(1):14-21.

PMID:
8868380
6.

Purification of collagen crosslinks; potential biomarkers for bone disorders.

McGuinness BJ, Casserly UM, Power MJ, Fottrell PF.

Biochem Soc Trans. 1995 May;23(2):386S. No abstract available.

PMID:
7672419
7.

Validation of a HPLC method for measurement of collagen crosslinks in urine-potential biomarkers for osteoporosis.

Casserly UM, McGuinness BJ, Power MJ, Fottrell PF.

Biochem Soc Trans. 1995 May;23(2):385S. No abstract available.

PMID:
7672418
8.

Development and validation of a monoclonal antibody enzyme immunoassay for measuring progesterone in saliva.

O'Rorke A, Kane MM, Gosling JP, Tallon DF, Fottrell PF.

Clin Chem. 1994 Mar;40(3):454-8.

9.

Follicular and luteal phase salivary progesterone profiles in women with endometriosis and infertility.

Wingfield M, O'Herlihy C, Finn MM, Tallon DF, Fottrell PF.

Gynecol Endocrinol. 1994 Mar;8(1):21-5.

PMID:
8059613
10.

Radioimmunoassay of 2-hydroxyestrone in urine.

McGuinness BJ, Power MJ, Fottrell PF.

Clin Chem. 1994 Jan;40(1):80-5.

11.
12.

Assessment of bioavailability of oral micronized progesterone using a salivary progesterone enzymeimmunoassay.

Bolaji II, Tallon DF, O'Dwyer E, Fottrell PF.

Gynecol Endocrinol. 1993 Jun;7(2):101-10.

PMID:
8213223
13.

Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters.

Bolaji II, Grimes H, Mortimer G, Tallon DF, Fottrell PF, O'Dwyer EM.

Eur J Obstet Gynecol Reprod Biol. 1993 Jan;48(1):61-8.

PMID:
8449263
14.

The frequency of salivary progesterone sampling and the diagnosis of luteal phase insufficiency.

Finn MM, Gosling JP, Tallon DF, Baynes S, Meehan FP, Fottrell PF.

Gynecol Endocrinol. 1992 Jun;6(2):127-34.

PMID:
1502930
15.

The return of postpartum fertility monitored by enzyme-immunoassay for salivary progesterone.

Bolaji II, Tallon DF, Meehan FP, O'Dwyer EM, Fottrell PF.

Gynecol Endocrinol. 1992 Mar;6(1):37-48.

PMID:
1580167
16.

Osteocalcin concentrations in plasma prepared with different anticoagulants.

Power MJ, O'Dwyer B, Breen E, Fottrell PF.

Clin Chem. 1991 Feb;37(2):281-4.

17.

Osteocalcin: diagnostic methods and clinical applications.

Power MJ, Fottrell PF.

Crit Rev Clin Lab Sci. 1991;28(4):287-335. Review.

PMID:
1930680
18.

Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily salivary progesterone.

Finn MM, Gosling JP, Tallon DF, Joyce LA, Meehan FP, Fottrell PF.

Gynecol Endocrinol. 1989 Dec;3(4):297-308.

PMID:
2626978
19.
20.

Direct solid-phase enzymoimmunoassay of testosterone in saliva.

Howard K, Kane M, Madden A, Gosling JP, Fottrell PF.

Clin Chem. 1989 Oct;35(10):2044-7.

Supplemental Content

Loading ...
Support Center